It is our policy to submit the patients affected by rectal cancer, T3 and T4, independently from N, to a neoadjuvant treatment with 50 Grays and FOLFOX chemotherapy. Surgery follows after 4–5 weeks, and it is preceded by a restaging procedure. In order to classify the down-staging of rectal tumors, we have adopted a score system (Table 1), inspired to the current TNM classification and based on imaging criteria.
Rectal cancer restaging after neoadjuvant chemoradiation: towards a down-staging system / Manenti, Antonio; Roncati, Luca; Salati, Massimiliano; Simonini, Emilio; Zizzo, Maurizio; Farinetti, Alberto. - In: JOURNAL OF GASTROINTESTINAL ONCOLOGY. - ISSN 2078-6891. - 8:1(2017), pp. 187-188. [10.21037/jgo.2016.10.04]
Rectal cancer restaging after neoadjuvant chemoradiation: towards a down-staging system
MANENTI, Antonio;RONCATI, LUCA;Salati, Massimiliano;Simonini, Emilio;Zizzo, Maurizio;FARINETTI, Alberto
2017
Abstract
It is our policy to submit the patients affected by rectal cancer, T3 and T4, independently from N, to a neoadjuvant treatment with 50 Grays and FOLFOX chemotherapy. Surgery follows after 4–5 weeks, and it is preceded by a restaging procedure. In order to classify the down-staging of rectal tumors, we have adopted a score system (Table 1), inspired to the current TNM classification and based on imaging criteria.
| File | Dimensione | Formato | |
|---|---|---|---|
|
Rectal cancer restaging after neoad chemoradiation.pdf
Open access
Descrizione: Articolo principale
Tipologia:
Versione pubblicata dall'editore
Dimensione
102.85 kB
Formato
Adobe PDF
|
102.85 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris
